What Fran Drescher's Story Can Help Us Understand About Uterine Cancer

Two years and eight doctors

Fran Drescher has told the story many times, and her foundation publishes it. She had symptoms she describes as subtle: bleeding between periods, and cramping after sex. Over two years, eight doctors told her the same thing. The agreement was that she was perimenopausal.

She had uterine cancer. She was diagnosed in 2000, and told an interview published by her foundation that she was still at stage one, with a slow-growing gynecologic cancer.

That is the whole point of the story she tells. Not the diagnosis, but the two years.

What uterine cancer is

The uterus is a hollow, pear-shaped organ. Its inner lining is called the endometrium. Almost all uterine cancers start there, which is why doctors usually say endometrial cancer.

It is common. The American Cancer Society projects about 68,270 new uterine cancer cases in the United States in 2026 and about 14,450 deaths, and SEER, the National Cancer Institute's statistics program, publishes that projection. Roughly 3.1 percent of women will be diagnosed with it at some point.

Estrogen is central to the risk. NCI lists estrogen-only hormone replacement therapy after menopause, tamoxifen taken for breast cancer, obesity, metabolic syndrome, and type 2 diabetes. It also lists conditions that expose the lining to more of the body's own estrogen: never giving birth, early periods, late menopause, and polycystic ovary syndrome. Family history in a mother, sister, or daughter counts, as do genetic conditions such as Lynch syndrome. Estrogen combined with progesterone does not raise the risk.

The one symptom that outranks the rest

NCI's list of signs is short:

• vaginal bleeding or discharge not related to periods.
• vaginal bleeding after menopause.
• difficult or painful urination.
• pain during sex.
• pain in the pelvic area.

Bleeding after menopause is the item to act on. Any bleeding at all, once periods have stopped for a year, needs an appointment. Not a wait-and-see. Not a follow-up at the next annual visit.

Before menopause the signal is harder to read, which is exactly the trap Drescher describes. Bleeding between periods, or periods that change pattern, can have many ordinary causes. They still deserve a look rather than an assumption.

How it gets confirmed

There is no screening test for endometrial cancer, and NCI says so plainly. There is no standard or routine screening test, and none is recommended for people at average risk. A Pap test screens for cervical cancer, not this.

That means diagnosis starts with symptoms. The main test is an endometrial biopsy. A thin, flexible tube is passed through the cervix into the uterus, and a small amount of the lining is gently scraped and sent to a pathologist. It is done in an office and takes minutes.

If the biopsy is unclear, the next step is dilatation and curettage. The cervix is opened and a spoon-shaped instrument called a curette removes more tissue. Our guide to cancer diagnosis covers what happens between the test and the result.

What treatment usually involves

NCI lists five standard treatments: surgery, radiation therapy, chemotherapy, hormone therapy, and targeted therapy.

Surgery leads. A total hysterectomy removes the uterus and cervix. It can be done through the vagina, through a large abdominal incision, or through small incisions with a camera. Tissue taken during that operation is also how the cancer is staged, so the surgery answers a question and treats the disease at once.

Radiation, chemotherapy, or hormone therapy may follow, depending on what the pathology shows. Our overview of uterine cancer walks through the stages in more detail.

What the outcome data show

Endometrial cancer is often found early, because bleeding is hard to ignore. About 67 percent of cases in SEER are still confined to the uterus at diagnosis. Another 18 percent have reached nearby lymph nodes, and 11 percent have spread further.

Five-year relative survival is 80.9 percent overall for people diagnosed between 2016 and 2022. By extent it is 94.9 percent for local disease, 70.1 percent when regional, and 19.9 percent when distant. Those are group averages. They describe a population, not a person, and they do not account for tumor type, which matters a great deal here.

When to make the call

Book an appointment, and say the word bleeding out loud, if:

• you have any vaginal bleeding after menopause, even spotting once.
• you bleed between periods, or your periods change pattern and stay changed for more than two or three cycles.
• you have unexplained pelvic pain or pain during sex that persists.
• you take tamoxifen and have any abnormal bleeding. NCI says transvaginal ultrasound should be used in women on tamoxifen who have vaginal bleeding.

If a clinician offers reassurance without a test, it is fair to ask directly whether an endometrial biopsy or a transvaginal ultrasound is warranted. Our page on cancer symptoms covers how to raise a concern that has been dismissed.

What this story cannot tell you

• One person's course is not a template. Stage, tumor type, and grade drive what happens next.
• A delayed diagnosis is not inevitable, and it is not the norm. Most postmenopausal bleeding is investigated promptly.
• Most abnormal bleeding is not cancer. Fibroids, polyps, and hormonal changes are far more common.
• There is still no screening test for this cancer. Attention to symptoms is what substitutes for one.

Sources

• Cancer Schmancer: exclusive interview with Fran Drescher
• Cancer Schmancer: it took 8 doctors to diagnose her uterine cancer
• NCI: Endometrial Cancer Treatment (PDQ) — Patient Version
• NCI: Endometrial Cancer Screening (PDQ) — Patient Version
• SEER Cancer Stat Facts: Uterine Cancer
• American Cancer Society: Cancer Facts & Statistics

How this page was made

An AI-assisted editorial system helped prepare this page. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown. Cancer Explained is published by the National Cancer Information Foundation as a nonprofit-oriented public-interest education project. It is not a diagnostic service, does not recommend treatments, and is not for emergencies.

Found an error, a broken source link, outdated information, or wording that feels insensitive? Report it here — we log and act on material corrections.